ArticleCancer gene therapy2007

CCL19 (ELC) as an adjuvant for DNA vaccination: induction of a TH1-type T-cell response and enhancement of antitumor immunity.

J Westermann et al.PubMed ↗Publisher ↗

No numbers read from the abstract.